OrbiMed Capital GP VIII LLC - Insider Non-Derivative Transactions at Kinnate Biopharma Inc. (KNTE) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on May 2, 2023, OrbiMed Capital GP VIII LLC's relationship to Kinnate Biopharma Inc. (KNTE) is Director,TenPercentOwner, and currently has 4,425,462 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other KNTE insiders.

Data Source: SEC.
OrbiMed Capital GP VIII LLC - Insider Non-Derivative Transactions of KNTE Common Stock
OrbiMed Capital GP VIII LLC - Insider Non-Derivative Transactions at KNTE
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
May 3, 2023 P -- (Common Stock) 58826 2.67 794368
May 3, 2023 P -- (Common Stock) 220610 2.67 4425462
May 2, 2023 P -- (Common Stock) 124544 2.62 735542
May 2, 2023 P -- (Common Stock) 124545 2.62 735542
May 2, 2023 P -- (Common Stock) 467068 2.62 4204852
Apr 29, 2023 P -- (Common Stock) 60997 2.55 610997
Apr 29, 2023 P -- (Common Stock) 60998 2.55 610998
Apr 29, 2023 P -- (Common Stock) 228754 2.55 3737784